# Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)

> **NCT05457790** · NA · SUSPENDED · sponsor: **National Cancer Institute (NCI)** · enrollment: 3 (actual)

## Conditions studied

- Sickle Cell Disease
- Sickle Cell Anemia
- Insomnia
- Sleeplessness
- Transient Insomnia
- Nonorganic Insomnia
- Chronic Insomnia

## Interventions

- **BEHAVIORAL:** ACT Intervention
- **BEHAVIORAL:** Waitlist

## Key facts

- **NCT ID:** NCT05457790
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-05-03
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study on hold pending consideration for amendment.
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05457790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05457790, "Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05457790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*